Glasgow, UK – Monday 11th September 2023: Glasgow diagnostics spinout Microplate Dx has closed a £2.5M seed funding round to develop its point-of-care diagnostic platform which can confirm the presence of bacteria and guide a Read More
Tags :Deepbridge Capital
Thalia, a UK-based company whose software platform enables semiconductor businesses to develop new products using existing chip designs, has raised £2.1m to drive the next phase of its growth. The funding round was led by Read More
BGF and Parkwalk lead £8.5m investment in Pathfinder Medical London, UK, 19 January 2022: Pathfinder Medical – a medical device company improving outcomes for vascular procedures – has secured an £8.5 million funding round led by investors BGF and Parkwalk, Read More
Aegiq secures seed investment to revolutionize trust in global telecommunications and computing with quantum photonics A quantum photonics spin-out from the University of Sheffield lands seven-figure investment from a syndicate, led by High-Tech Gründerfonds, Read More
SmallSpark Space Systems to ignite following investment raise SmallSpark Space Systems, the award-winning rocket propulsion innovation company, is set to reach new heights as they announce a £500,000 scale-up investment from Deepbridge Capital, in a deal Read More
Glyconics© secures £1.5million in over-subscribed raise for pioneering diabetes screening tool guiding diagnostics Award-winning medtech firm, Glyconics© has secured £1.5million in an Enterprise Investment Scheme (EIS) funding round ahead of a series A round next Read More
19th October 2021, London: Event tech scale-up, HeadBox, has finalised a £2 million fundraise led by Deepbridge Capital, bringing their total funding to £13.2 million. This investment will help HeadBox to accelerate out of the pandemic, fueling Read More
Zilico Ltd announces Further Investment and the Appointment of a new Chair of the Board of Directors Early cancer diagnostic specialist, Zilico Ltd, has today announced further investment from existing investor, Deepbridge Capital and the Read More
Funding from Deepbridge Capital will support development of next generation biologics January 10th 2020: Aberdeen, Scotland: Elasmogen Ltd, the biopharmaceutical company leading the development of soloMERTM biologics, today announced it has secured follow-on Read More
Will accelerate customer engagement and expansion into USA; further broaden technology development Thalia Design Automation today announced that it plans significant growth in its worldwide operations, following completion of a $2m (£1.52m) funding round led Read More